Cellcept and Megestrol acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Megestrol acetate (megestrol acetate). Common drug interactions include chronic graft versus host disease among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Megestrol acetate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Megestrol acetate?

Megestrol acetate has active ingredients of megestrol acetate. It is often used in appetite - decreased. eHealthMe is studying from 5,427 Megestrol acetate users. Check the latest studies of Megestrol acetate.

On Aug, 03, 2026

14 people who take Cellcept and Megestrol acetate together, and have interactions are studied.

Cellcept and Megestrol acetate drug interactions.

What are the common drug interactions of Cellcept and Megestrol Acetate, by gender? *:

female:

Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Colitis (inflammation of colon)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Diarrhoea
Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
Dry mouth
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Epistaxis (bleed from the nose)
Febrile neutropenia (fever with reduced white blood cells)

male:

Anxiety
Fatigue (feeling of tiredness)
Foot deformity (functional disability of foot)
Gait disturbance
General physical health deterioration (weak health status)
Hypoaesthesia (reduced sense of touch or sensation)
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Mobility decreased (ability to move is reduced)
Muscle atrophy (a decrease in the mass of the muscle)

What are the common drug interactions of Cellcept and Megestrol Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arthralgia (joint pain)
Balance disorder
Dysstasia (difficulty in standing)
Emotional distress
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Foot deformity (functional disability of foot)

30-39:

n/a

40-49:

Skin tightness
Erythema (redness of the skin)
Exfoliative rash (scaly red generalized skin rash)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Skin hyperpigmentation (disorders affect the colour of your skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Atrophy (wasting away of a part of the body)

50-59:

Abdominal mass (localized enlargement or swelling in the human abdomen)
Abdominal pain
Aphthous ulcer (mouth ulcer)
Bacterial sepsis
Catheter site haematoma (blood clot at catheter site)
Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Colitis (inflammation of colon)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Diarrhoea

60+:

Aggression
Anaemia (lack of blood)
Cough
Diarrhoea
Dizziness
Dyspnoea (difficult or laboured respiration)
Failure to thrive (inadequate weight gain and physical growth in children)
Fall
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 7 people, 50.00%
Pain: 6 people, 42.86%
Nuclear Magnetic Resonance Imaging Brain: 6 people, 42.86%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 28.57%
Urination - Excessive At Night: 2 people, 14.29%
Loss Of Consciousness: 2 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 2 people, 14.29%
Complications Of Transplanted Lung: 2 people, 14.29%
Constipation: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Megestrol acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously